Drug Approval Package
  • Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

Drug Approval Package

  • Print
  • Share
  • E-mail
-

ZANTAC INJECTION (RANITIDINE HYDROCHLORIDE)
Company:  Glaxo Wellcome Inc.
Application No.:  019090, S37
Approval Date: 10/29/1999

Back to Top    Drugs@FDA
-

-

PDF document PDF requires the free Adobe Acrobat Reader

Date created: April 16, 2003

 

Date created: April 04, 2002

Back to Top    Drugs@FDA

 

Note: Documents in PDF format require the Adobe Acrobat Reader®.

-
-